MAUDE MDR 6897719

MDR report key
6897719
Report number
3007566237-2017-04083
Event key
0
Event type
3
Date received
2017-09-27
Adverse event
3
Product problem
3
Patients in event
0
Reporter occupation
0
Health professional
3
Initial report to FDA
3
Event location
3

Manufacturer Contact#

Contact
LISA WOODWARD CLARK
Address
7000 CENTRAL AVENUE NE RCW215 MINNEAPOLIS MN 55432 US
Phone
763-763-7635
Report source
M
Manufacturer link flag
Y

Devices#

Seq, Brand, Generic table
SeqBrandGenericManufacturerProduct codeModelCatalogLotPMA510(k)ImplantEvaluatedAvailability
1NUROSTIMULATOR,PERIPHERAL NERVE,NON-IMPLANTED,FOR PELVIC FLOOR DYSFUNCTIONMEDTRONIC NEUROMODULATIONNAM35333533* N

Patients#

Sequence, Received, Treatment table
SequenceReceivedTreatmentOutcome
12017-09-2701. R

Event Narratives#

N

Patient 1

A GOOD FAITH EFFORT WILL BE MADE TO OBTAIN THE APPLICABLE INFORMATION RELEVANT TO THE REPORT. IF INFORMATION IS PROVIDED IN THE FUTURE, A SUPPLEMENTAL REPORT WILL BE ISSUED.

D

Patient 1

THE PATIENT REPORTED THAT THEY HAD PULLED MUSCLES AND WERE ON MEDICATION THAT SET THEIR SYMPTOM RELIEF BACK WITH THE PERCUTANEOUS TIBIAL NEUROMODULATION (PTNM) THERAPY. THEY INDICATED THAT THEY DIDN'T HAVE THE CONTROL THEY HAD BEFORE THEY STARTED TAKING THE MUSCLE RELAXANTS AND PAIN PILLS FOR THEIR PULLED MUSCLES. THE PATIENT STATED THAT A WEEK FOLLOWING THIS, THEY FOUND OUT THEY HAD A URINE INFECTION, AND WERE PLACED ON MEDICATION FOR THREE DAYS. IT WAS NOTED THAT THEY DID NOT HAVE SYMPTOMS, ONLY LOWER BACK PAIN. THEY THOUGHT THIS WAS BECAUSE THE MUSCLE SPASMS WEREN'T GETTING BETTER. THE HEALTHCARE PROVIDER (HCP) DECIDED TO TAKE A URINE SAMPLE, AND IT WAS DETERMINED THAT THE PATIENT HAD A URINE INFECTION. THIS WAS THE FIRST THAT THE PATIENT HAD EVER HAD. IT WAS INDICATED THAT THEY WERE WAITING TO SEE IF THEY STILL HAD ONE. THEY DIDN'T THINK SO BECAUSE THEIR URGENCY HAD BEEN BETTER IN THE LAST COUPLE OF WEEKS. THERE WERE NO FURTHER COMPLICATIONS REPORTED AS A RESULT OF THIS EVENT.

N

Patient 1

IF INFORMATION IS PROVIDED IN THE FUTURE, A SUPPLEMENTAL REPORT WILL BE ISSUED.

N

Patient 1

IF INFORMATION IS PROVIDED IN THE FUTURE, A SUPPLEMENTAL REPORT WILL BE ISSUED.

D

Patient 1

ADDITIONAL INFORMATION RECEIVED FROM THE PATIENT INDICATED THAT THEY HAD COMPLETED 14 SESSIONS. THE PATIENT LATER PROVIDED CONTRADICTING INFORMATION THAT THEY WENT THROUGH 14 SESSIONS, AND THEN HAD TWO EXTRA ONES. THEY STATED THAT THEY HAD STARTED THE THERAPY AT THE END OF (B)(6) 2017, AND IT WAS EFFECTIVE AND PERFECT. ALL SYMPTOMS WERE NEARLY GONE. IT WAS INDICATED THAT IT WAS GOING SO WELL THE FIRST FEW WEEKS UNTIL THEY HURT/PULLED THEIR BACK A COUPLE MONTHS INTO IT. THEY DIDN'T HAVE ANY FALLS OR TRAUMA, THEY HAD A BAD BACK AND "SOMETIMES IT HAPPENS." THEY MENTIONED THAT THE SESSIONS DIDN'T HELP STARTING IN (B)(6) 2017. THEY WERE BACK TO SQUARE 1, AND WERE AS BAD AS PRIOR TO STARTING THE THERAPY. THEY DIDN'T KNOW IF THE THERAPY NO LONGER WORKING WAS DUE TO THEM HURTING THEIR BACK, THE MEDICATION THEY WERE ON, OR THEM GETTING A URINARY INFECTION IN (B)(6)2017. IT WAS NOTED THAT THE PATIENT WAS ON ORAL MEDICATION FOR THE INFECTION FOR THREE DAYS, WHICH TOOK CARE OF IT. THE PATIENT ALSO REPORTED THAT THEY NEVER FELT STIMULATION IN THEIR BICYCLE SEAT AREA, BUT WHEN THEY WOULD TURN UP THE "SIGNAL" TO THE POINT WHERE THEIR FOOT WOULD TINGLE, SOMETIMES IT WOULDN'T, AND SOMETIMES IT HURT ON THE INSERTION SITE. THERE WERE NO FURTHER COMPLICATIONS REPORTED AS A RESULT OF THIS EVENT.